Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/06/2012CA2875025A1 Tricyclic inhibitors of poly(adp-ribose)polymerase
12/06/2012CA2874998A1 Methods, compositions, and kits for the treatment of cancer
12/06/2012CA2843470A1 Brain tumor targeting peptides and methods
12/06/2012CA2838125A1 In situ antigen-generating cancer vaccine
12/06/2012CA2838023A1 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
12/06/2012CA2837758A1 Polymorphism panels predictive of anthracycline-induced cardiotoxicity (act)
12/06/2012CA2837654A1 Methods and uses for ex vivo tissue culture systems
12/06/2012CA2837630A1 Substituted aminoimidazopyridazines
12/06/2012CA2837586A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837556A1 Antibodies specific for tgf-beta
12/06/2012CA2837548A1 Combined pharmaceutical compositions for the treatment of tumorous diseases
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/06/2012CA2837167A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837042A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012CA2835963A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012CA2835760A1 Methods of treating mesothelioma with a pi3k inhibitor compound
12/06/2012CA2834194A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
12/05/2012EP2530150A1 Transformation plasmid
12/05/2012EP2530091A1 Anti-dll3 antibody
12/05/2012EP2530081A2 Nilotinib HCI crystalline forms
12/05/2012EP2530080A1 Method for manufacturing polymethoxyflavones that are highly stable over time and have reduced residual pesticide levels
12/05/2012EP2529758A2 Vitamin receptor binding drug delivery conjugates
12/05/2012EP2529754A1 Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
12/05/2012EP2529622A1 Inhibitors of bruton's tyrosine kinase
12/05/2012EP2529621A1 Inhibitors of bruton's tyrosine kinase
12/05/2012EP2528937A1 Modified melk peptides and vaccines containing the same
12/05/2012EP2528925A2 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
12/05/2012EP2528918A1 6,7- dihydroimidazo [1,5-a]pyrazin-8 (5h) - one derivatives as protein kinase modulators
12/05/2012EP2528917A1 Pyrazolopyridine kinase inhibitors
12/05/2012EP2528916A1 Pyrazolopyridine kinase inhibitors
12/05/2012EP2528910A1 5-alkynyl pyrimidines and their use as kinase inhibitors
12/05/2012EP2528909A1 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
12/05/2012EP2528904A1 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes
12/05/2012EP2528903A1 5-alkynyl-pyrimidines
12/05/2012EP2528897A1 Di - substituted pyridine derivatives as anticancers
12/05/2012EP2528893A2 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders
12/05/2012EP2528627A2 Radioimmunoconjugates and uses thereof
12/05/2012EP2528625A1 Pyrrolobenzodiazepines and conjugates thereof
12/05/2012EP2528613A1 Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates
12/05/2012EP2528440A1 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
12/05/2012EP2528437A1 Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
12/05/2012CN202568935U Medicinal fungus lozenge structure for inhibiting tumor
12/05/2012CN1981749B Use of beta-elemene for inhibiting cerebrovascular endothelial cell
12/05/2012CN102812047A Anti-C4.4a Antibodies And Uses Thereof
12/05/2012CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same
12/05/2012CN102812027A Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/05/2012CN102812022A Thiazole and oxazole kinase inhibitors
12/05/2012CN102812013A Novel Kinase Modulators
12/05/2012CN102811746A Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/05/2012CN102811743A Stable Formulations For Lyophilizing Therapeutic Particles
12/05/2012CN102811742A Carbohydrate-polyamino acid-drug conjugates
12/05/2012CN102811721A Treating Neurotoxicity Associated With Combinations Of 5 - FU Or Its Prodrugs And DPD Inhibitors
12/05/2012CN102808016A Applications of ARID1A gene and protein product encoded by the same
12/05/2012CN102807620A Method for forming targeted chemotherapeutic agents for treating infectious and malignant diseases
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807606A Oligopeptide with antitumor and antiadhesion activities and synthesis method and application thereof
12/05/2012CN102807603A Aliphatic amine chain modified anti-tumor oligopeptide and synthetic method and application thereof
12/05/2012CN102807576A Novel fat-soluble binuclear Cu (II) anticancer complex
12/05/2012CN102807574A Novel pyrido sulfur nitrogen 7-membered ring derivatives adopted as anti-tumor drugs, preparation method and applications thereof
12/05/2012CN102807568A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor
12/05/2012CN102807566A 1,7-diaryl-1,6-trans-diene-3,5-diketone as well as preparation method and application thereof
12/05/2012CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor
12/05/2012CN102807548A Norathyriol crystal I and preparation method thereof
12/05/2012CN102807526A Preparation method and application of histone deacetylase inhibitor ZYJ-D08a and epimer thereof
12/05/2012CN102807514A Substituted phenylenediamine derivative and preparation method and application thereof
12/05/2012CN102807508A Acetaminophen ketone derivative and preparation method and application thereof
12/05/2012CN102807501A Non-natural chiral amino acid and biological catalysis desymmetrisation preparation method thereof
12/05/2012CN102805873A Gene drug co-carrier system using cation liposome to establish gold nano-spherical shell and preparation method
12/05/2012CN102805870A Gold nano-spherical shell carrier with procedural gene drug release property and preparation method
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805867A Application of transcription factor NFATC3 as drug target in reversing multidrug resistance of tumor
12/05/2012CN102805861A Lactate dehydrogenase A acetylation activator and application thereof
12/05/2012CN102805860A Inhibitor for acetylation of pyruvate kinase 2 (PKM2) and use thereof
12/05/2012CN102805859A Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo
12/05/2012CN102805844A Medicine for treating liver cancer
12/05/2012CN102805840A Complex anti-tumor traditional Chinese medicine preparation
12/05/2012CN102805836A Chinese traditional medical composition for treating primary hepatic carcinoma and preparation method thereof
12/05/2012CN102805829A Preparation method of rhizoma smilacis glabrae extract and applications thereof in tumor treatment
12/05/2012CN102805799A Traditional Chinese medicine composition with antitumous effect
12/05/2012CN102805789A Application of alocasia eucullatta (Dour) Schott and extract thereof in preparation of cervical cancer drugs
12/05/2012CN102805768A Application of catclaw buttercup root extract to preparation of anti-lung cancer medicines
12/05/2012CN102805761A Medicament for treating leukemia
12/05/2012CN102805756A Application of extract of Chimonanthus Salicifolius. S.Y.H. in preparation of gastric cancer treating medicine
12/05/2012CN102805755A Preparation method of high-quality ginkgo flavone
12/05/2012CN102805747A Use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine in pharmacy
12/05/2012CN102805743A Application of arctigenin in treating angiogenesis diseases
12/05/2012CN102805742A Indometacin target capsules for colons and preparation method thereof
12/05/2012CN102805730A Ceramide liposome and preparation method and application thereof
12/05/2012CN102805729A Vinflunine liposome preparation and preparation method of vinflunine liposome preparation
12/05/2012CN102805724A Vitamin A acid cream and preparation method thereof
12/05/2012CN102406652B Application of forsythin in preparation of medicines for treating chronic myeloid leukemia
12/05/2012CN102391499B Preparation method of polymer for quickly releasing active components of masticinic acid under exciting of reduction
12/05/2012CN102352356B Bcl11a siRNA-2292 restraining expression of BCL11A and proliferation of tumorous B cells and application thereof
12/05/2012CN102327227B Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid
12/05/2012CN102302784B Tumor chemotherapeutic medicinal preparation and preparation method thereof
12/05/2012CN102274510B Preparation method of carbon nanotube-chitosan-phycocyanin nanoparticles
12/05/2012CN102274237B Novel application of flavonoid compound
12/05/2012CN102274190B Paclitaxel alhumin submicron for injection and preparation method thereof
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 2211